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A B S T R A C T
To identify an effective ligand that binds to a G-quadruplex structure but not a double-stranded DNA (dsDNA), a set
of biophysical and biochemical experiments were carried out using newly synthesized cyclic ferrocenylnaphthalene di-
imide (cFNDI, 1) or the non-cyclic derivative (2) with various structures of G-quadruplex DNAs and dsDNA. Com-
pound 1 bound strongly to G-quadruplexes DNAs (106 M−1 order) with diminished binding to dsDNA (104 M−1 order) in
100 mM AcOH-AcOK buffer (pH 5.5) containing 100 mM KCl. Interestingly, 1 showed an approximately 50-fold higher
selectivity to mixed hybrid-type telomeric G-quadruplex DNA (K = 3.4 × 106 M−1 and a 2:1 stoichiometry) than dsDNA
(K = 7.5 × 104 M−1) did. Furthermore, 1 showed higher thermal stability to G-quadruplex DNAs than it did to dsDNA
with a preference for c-kit and c-myc G-quadruplex DNAs over telomeric and thrombin binding aptamers. Additionally,
1 exhibited telomerase inhibitory activity with a half-maximal inhibitory concentration (IC50) of 0.4 μM. Compound 2
showed a preference for G-quadruplex; however, the binding affinity magnitude and preference were improved in 1 be-
cause the former had a cyclic structure.
© 2016 Published by Elsevier Ltd.
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G-quadruplex-forming sequences occur at the ends of eukaryotic
chromosomes and are known as telomeres, and they also exist in other
vital regions of the genome as oncogene promoters, introns, 5′-UTR
regions, or aptamers.1–3 The G-quadruplex is a four-stranded nucleic
acid structure produced by guanine-rich repeating sequences such as
TTAGGG, which are composed of π-π-stacked on guanine tetrads
(G-tetrads) by Hoogsteen-bonds.2 The structure, stability, and topol-
ogy of G-quadruplex DNAs depend on numerous factors such as the
sequence, length of the loops, and mainly the presenting metal ions.3
For instance, the human telomeric DNA can fold into a mixture of
G-quadruplex topologies (parallel, antiparallel, and hybrid) in vitro
under physiological conditions, compared to duplex DNAs.4 The for-
mation of G-quadruplex structures can regulate the transcriptional and
translational activity of telomerase, expression of oncogenes, or both
in the body. The telomere contains the length of the telomere DNA
and is involved in approximately 85% of all cancers.
Molecules that stabilize G-quadruplex structures can inhibit telom-
erase or oncogene activities, or both and, thereby, inhibit intermittent
cancer progression.5 These molecules are considered potential anti-
cancer therapeutic agents.6–9 Notably, G-quadruplex-forming activity
is very low in human somatic cells. Therefore, one of the major chal-
lenges in this field is to design a suitable new molecule as a ligand
that selectively binds to G-quadruplex over dsDNA and exhibits lig-
and specificity toward a particular G-quadruplex topology.
⁎ Corresponding author at: Department of Applied Chemistry, Kyushu Institute of
Technology, Kitakyushu 804-8550, Japan.
Email address: shige@che.kyutech.ac.jp (S. Takenaka)
Numerous ligands that preferentially bind G-quadruplex DNAs
over duplex DNA have been reported over the past few decades. These
ligands are well studied as G-quadruplex stabilizers both in vitro
and in vivo that exhibit anticancer activity.6–8 However, their bind-
ing affinities are still nonselective, as they show affinity to duplexes
and other structures. Previously, we reported the synthesis and interac-
tion studies of numerous cyclic naphthalene diimide (NDI) derivatives
with G-quadruplex DNAs and dsDNA.10–13 Furthermore, other macro-
cyclic NDI derivatives have been synthesized and studied by Marche-
tti et al.14 to investigate their interaction with DNAs. These cyclic lig-
ands showed versatile binding characteristics to G-quadruplex DNAs
and dsDNA. We had numerous questions about the selectivity of these
ligands to G-quadruplex DNAs over dsDNA including cyclic ligands
with substituents or chain variations. These cyclic ligands were syn-
thesized by cyclization with benzene or cyclohexane ring with two
types of connecting chains (Fig. 1).
We hypothesized that these rings might have some beneficial or
harmful effects on their binding with G-quadruplex DNAs or ds-
DNA, respectively. Particularly, the cyclohexane fused ring struc-
ture is more flexible during the binding with dsDNA than it is with
other DNAs. It cannot contribute to the intercalation with dsDNA, but
it may be partially stacked on dsDNA, which consequently reduces
binding with dsDNA. However, the cyclohexane rings in cyclic lig-
ands do not have beneficial effects on their binding with G-quadru-
plex DNAs because the interaction between the cyclohexane ring
and the loop part of the G-quadruplex DNAs has no positive ef-
fect. On the other hand, the benzene ring in cyclic ligands may have
a suitable effect on their binding with G-quadruplex DNAs be
http://dx.doi.org/10.1016/j.bmcl.2016.11.037
0960-894/© 2016 Published by Elsevier Ltd.
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Fig. 1. Chemical structures of 1 and 2 with cNDI carrying benzene9 or cyclohexyl10 parts.
cause of the π-π overlapping between the benzene ring and nucleic
base in the loop part of the G-quadruplex DNA. However, the benzene
ring of cyclic ligands can go through the dsDNA base pair, resulting
in intercalation such as bis-intercalation or catenation and, thus, the
selectivity of cyclic ligands to G-quadruplex DNAs over dsDNA is re-
duced.
To address the above challenges and discover suitable cyclic lig-
ands that selectively bind to G-quadruplex DNAs over dsDNA, we
designed and synthesized a new cyclic ligand by cyclization using
thick and rigid substituent such as ferrocene. We predicted that the fer-
rocene in the cyclic ligand might facilitate its binding with G-quadru-
plex loop through π-π overlapping and at the same time, the ferrocene
moiety would prevent the intercalation or catenation binding with ds-
DNA. On the other hand, the thickness and rigidity of the ferrocene
moiety should strengthen the cyclic structure and decrease the flexibil-
ity, and thereby reduce the binding to dsDNA. With this aim in mind,
we synthesized cyclic ferrocenylnaphthalene diimide (cFND, 1) by
connecting NDI and ferrocene through an alkyl chain, piperazine, and
amide group. The amide part of the linker chain of 1 may reduce the
binding affinity to dsDNA because one face of the intercalator (NDI
moiety) covered the hindered alkyl chain and, consequently, reduced
intercalation to dsDNA. Furthermore, these new types of cyclic mole-
cules may facilitate end stacking onto the G-quartet plane using a sin-
gle face of the NDI moiety or both faces of NDI or ferrocene moiety.
In this study, we also investigated compound 2, which was reported to
be a dsDNA binder that exhibits threading intercalation15 with differ-
ent types of G-quadruplex DNAs and dsDNAs, as a negative control
to strengthen the evidence supporting the macrocyclization approach.
We attempted to differentiate the binding properties of cyclic 1 and
non-cyclic 2 with the DNAs and determine their selectivity towards
the G-quadruplex DNA.
We aimed to determine the selectivity of 1 and 2 towards
G-quadruplex DNAs and dsDNA, by examining the interaction of
these ligands with G-quadruplex DNA carrying a human telomeric
region (a-core and a-coreTT), promoter region (c-myc and c-kit), or
thrombin-binding aptamer (TBA) and dsDNA. These different confor-
mations of G-quadruplex DNAs were confirmed using circular dichro-
ism spectra. A detailed evaluation of the selective binding of com-
pound 1 and 2 with the G-quadruplex DNAs over dsDNA was car-
ried out using ultraviolet–visible (UV–vis) titration, circular dichroism
(CD) titration, CD melting, and UV–vis melting, as well as fluores-
cence resonance energy transfer (FRET) melting, topoisomerase I iso-
merase, and telomeric repeat amplification protocol (TRAP) assays.
To investigate the binding properties of 1 and 2 with various
G-quadruplex DNAs and dsDNA, spectrophotometric titrations were
carried out. In particular, we focused our attention on differentiating
the binding properties between G-quadruplex DNAs and dsDNA, as
well as the telomeric and non-telomeric G-quadruplex DNA. Fig. 2A
depicts an example of the interaction between 1 and the human telom-
ere G-quadruplex DNA (a-core) in K+ ion, which revealed that the
highest absorption was at 384 nm. After adding the pre-annealed
a-core DNA to 1, large hyperchromicities (45–60%) and small red-
shifts (3–8 nm) were observed, which indicate the strong stacking in-
teraction and specific mode of binding with G-quadruplex DNAs.10
On the other hand, the interaction of 1 with dsDNA showed
hypochromic (25–30%) and red (2–4 nm) shifts that were smaller
than those observed with the G-quadruplex DNAs. This result sug-
gests that this compound is not a good dsDNA binder (Fig. 2B). The
Scatchard plot (Fig. 2C) of the G-quadruplex DNA was analyzed us-
ing the McGhee–von Hippel Scatchard equation to obtain a binding
constant (K) and the ratio of 1 per DNA n value.16 Furthermore, the
nK values of the dsDNA were estimated using the Benesi–Hildebrand
method because the binding saturation of 1 with dsDNA was not ob-
served.17 Compound 1 showed a binding affinity with G-quadruplex
DNAs in the range of 106 M−1 with a stoichiometry of 2:1 (ligand/
DNA). Furthermore, 1 did not show any significant binding affin-
ity to dsDNA in the range of 104 M−1 order, which indicates that its
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Fig. 2. Spectral shifts of 5 μM 1 on titration with 0, 1.4, 2.9, 4.4, 5.8, 8.7 and 14 μM a-core (A) or 0, 2, 5, 10, 20, 30, and 40 μM dsDNA (B) in 100 mM AcOH-AcOK buffer (pH 5.5)
containing 100 mM KCl. Scatchard plots for binding of 1 to a-core (C) and Benesi-Hildebrand plot for binding of 1 to dsDNA (D).
specificity to G-quadruplex was approximately 50-fold higher than
that to dsDNA.
As shown in Table 1, the binding constants in the K+ ion were
K = 3.4 × 106 M−1 for a-core (mixed hybrid type),18 K = 2.6 × 106 M−1
for a-coreTT (hybrid type-2),19 K = 2.0 × 106 M−1 for TBA (antiparal-
lel chair type),20 K = 2.0 × 106 M−1 for c-kit (parallel propeller type),21
and K = 1.9 × 106 M−1 for c-myc (parallel type)22 with 1, which were
50, 35, 26, 26, and 25 times higher binding preferences over ds-
DNA (K = 7.5 × 104 M−1) respectively.
Table 1
Binding parameters and melting temperatures of 1 and 2 with a-core, a-coreTT, c-kit,
c-myc, TBA, and dsDNA.
DNAs 10−6 K/M−1 (n)a Tm/°C ΔTm/°C
1 2 1 2
a-core 3.4 ± 0.3 (2.1)b 1.4 ± 0.3 (2.9)b 69d 10 5
a-coreTT 2.6 ± 0.3 (2.1)b 1.6 ± 0.2 (2.5)b 64d 7 6
TBA 2.0 ± 0.3 (1.4)b 1.9 ± 0.1 (2.8)b 51d 5 8
c-kit 2.0 ± 0.2 (2.3)b 2.0 ± 0.1 (4.0)b 54e 18 15
c-myc 1.9 ± 0.4 (2.4)b 1.8 ± 0.3 (3.4)b 70f 17 18
dsDNA 0.075c 1.0 ± 0.1 (3.0)b 49d 2 3
g[ligand]:[DNA] = 2:1 in 100 mM AcOH-AcOK buffer (pH 5.5) in 5.0 mM KCl.
a 100 mM AcOH-AcOK buffer (pH 5.5) and 100 mM KCl.
b Scatchard analysis (K and n).
c Bensi-Hildebrand analysis (nK).
e [ligand]:[DNA] = 2:1 in 100 mM AcOH-AcOK buffer (pH 5.5) in 100 mM KCl.
f [ligand]:[DNA] = 2:1 in 100 mM AcOH-AcOK buffer (pH 5.5) in 20 mM KCl.
The binding stoichiometry of 1 with the G-quadruplex DNA was es-
timated at 2:1 using a Scatchard plot (Supporting information Fig.
S4), which may correspond to end-stacking binding to the external
G-quartet planes. In Table 1, the binding constant data indicate that
1 had a binding affinity that was almost similar to that its affinity
with different types of G-quadruplex DNAs. We found similar re-
sults in the FRET melting assay, which showed that the binding ac-
tivities of 1 with the different G-quadruplex structures were compara-
ble (Supporting information Fig. S5).23 The binding constant and stoi-
chiometry of 1 with G-quadruplex DNAs were consistent with the pre-
vious results obtained by Czerwinska et al.10 It seems that the binding
of 1 with the G-quadruplex DNAs may completely overlap with the
G-tetrads. Moreover, the amide part of the linker chain of 1 may be
more compatibility and, therefore, bind specifically with the G-quar-
tet plane. However, we clearly observed that the binding of 1 with ds-
DNA reduced more than its binding with G-quadruplex DNA did due
to the linker chain of the cFNDI derivatives and the NDI or ferrocene
moieties, which also prevented its binding to dsDNA.
In contrast, compound 2 exhibited a lower binding affinity to the
G-quadruplex DNAs (K = 1.4 × 106 M−1) than 1 did. In addition, com-
pound 2 showed a trend of stoichiometry that was similar to that
of 1 because the binding of 2 with the G-quadruplex DNAs might
not have completely overlapped with the G-tetrads, as opposed to
the complete overlap observed with 1. However, 2 still showed a
higher affinity to dsDNA (K = 1.0 × 106 M−1) than 1 did because of
the threading intercalation complex formed by the penetration of the
dsDNA base pair of the linear chain of 2.11,12,24 Therefore, the dif-
ference in the binding constants observed between the G-quadruplex
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DNA and dsDNA clearly explains the specificity and selectivity of
these ligands.
CD spectroscopy emerged as a useful technique for investigating
the binding interaction of 1 and 2 with the G-quadruplex DNA (an-
nealed with K+ buffer) structure chromophore. We focused on the hy-
brid, parallel, and antiparallel G-quadruplex DNAs to investigate the
interaction between the ligands and various G-quadruplex topologies.
The CD spectra of the human telomere G-quadruplex DNAs (a-core
and a-coreTT) revealed positive, negative, and shoulder peaks at 290,
240, and 265 nm, respectively (Fig. 3A and B) in buffer containing
100 mM KCl. This result indicates a mixed hybrid type (hybrid-1 and
-2) for the a-core and hybrid-2 types for a-core TT in the G-quadru-
plex DNA structures.25,26 Following the addition of 1 or 2, a dose-de-
pendent increase in the CD signals was observed, suggesting that the
pre-folded mixed hybrid type (hybrid-1 and hybrid-2) and hybrid-2
type G-quadruplex DNA structures were retained. However, the TBA
G-quadruplex DNA (Fig. 3C) revealed a negative band at 250 nm
and a positive peak at 290 nm, suggesting an anti-parallel chair type
G-quadruplex structure.27 Following the addition of 1, the positive
peak at 290 nm gradually increased and the peak around 250 nm grad-
ually decreased for TBA, indicating that the binding of 1 apparently
caused no further significant change in the G-quadruplex DNA struc-
ture.27 Remarkably, 1 caused a more significant increase in the ellip-
ticity than 2 did, which was probably due to aggregation (Supporting
information Fig. S6).
Furthermore, the promoter regions of the G-quadruplex DNA
(c-myc and c-kit) exhibited a parallel structure in the presence of
K+ ions, which showed a negative peak at 241 nm, a positive peak
centered around 262 nm, and a small shoulder peak at 290 nm
(Fig. 3D and E).28,29 The CD spectra gradually decreased at 241 and
262 nm with no other significant change in the spectrum following
the addition of 1 or 2, which suggests the ligand-dependent disrup-
tion stacking of the G-quadruplex DNA, which is the parallel struc-
ture, was retained. Interestingly, the c-kit structure showed a shoulder
peak at 290 nm that increased slightly following the addition of the
ligands, which was consistent with the results of a previous report.30
Particularly, 1 revealed a more noteworthy decrease in ellipticity than
2 did (Supporting information Fig. S6). The binding stoichiometry of
the Scatchard plot was confirmed to be 2:1 using a Job plot analysis
for 1 and 2 with G-quadruplex DNA (Supporting information Figs. S7
and S8).31
To find out more details about the binding modes of these ligands,
we carried out a topoisomerase I assay. Topoisomerase-based gel as-
says are widely recognized method used to evaluate ligands for their
ability to intercalate into DNA.32 We used a topoisomerase I assay to
confirm the intercalation of 1 and 2 with supercoiled DNA. The topoi-
somerase I enzyme unwinds the supercoiled DNA into relaxed DNA.
However, in the presence of the intercalator, the relaxed DNA re-con-
verted into supercoiled DNA while the groove binder cannot re-super-
coil DNA because of the negligible DNA unwinding with the bind-
ing.33 In Fig. S9, the gel electrophoresis indicates that the relaxed plas-
mid DNA, pU19 completely re-supercoiled with compounds 1 and 2
in the presence of topoisomerase I enzyme, indicating that both com-
pounds are DNA intercalators. In contrast, the groove binder did not
show intercalating behavior. Cyclic structured compounds unwind the
DNA and lengthen its structure because cyclic structured compounds
require the DNA strands to dissociate. We previously reported that
cyclic compounds show a slow dissociation rate from the duplex struc-
ture.12 We also reported that cyclic-NDI derivatives can re-supercoil
plasmid DNA,9,10 which is consistent with the results of our present
study.
Thermal stabilization of the DNA structure following binding with
1 or 2 was examined (2:1, ligand/DNA ratio) using CD and UV–vis
melting assays using the specific detection wavelengths of the DNAs
in the absence and presence of the molecules. All the thermal de-
naturation was monitored at the wavelengths of maximum CD inten-
sity. Without compound 1, the Tm value was recorded at approxi-
mately 69 and 63 °C for a-core and a-coreTT, respectively (Table 1,
Fig. 4A and B) with an ellipticity at 290 nm. After the addition of 1,
the telomeric DNA quadruplex increased the thermal stability by 10
and 7 °C for the a-core and a-coreTT, respectively. At 290 nm wave-
length, 1 increased the Tm of TBA by 5 °C (Table 1 and Fig. 4C),
which are consistent with the results of previous reports.23,27
At a high salt concentration, the c-kit and c-myc G-quadruplex
DNAs were highly stable, and the baseline curve was not achieved
even at temperatures above 90 °C, but it was not possible to measure
an accurate Tm in this case. Therefore, we measured the stability of
c-kit and c-myc G-quadruplex DNAs at a low salt concentration. Com-
pound 1 increased the Tm of c-kit by 18 °C and that of c-myc by 17 °C
(Table 1 and Fig. 4D and E), which were monitored at 263 nm under
K+, supporting the results of our previous reports.29,30 On the other
hand, the UV–vis melting study of 1 with dsDNA revealed that the
Tm increase by 2 °C, indicating that 1 was more highly stabilized with
the G-quadruplex DNA than it was with dsDNA (Table 1, Supporting
information Fig. S10). Compound 2 showed a lower melting profile
with the G-quadruplex DNA than 1 did, and 2 also exhibited a higher
Tm of up to 3 °C with dsDNA (Table 1, Supporting information Figs.
S11 and S12), indicating its intercalation into the dsDNA. Remark-
ably, the CD melting studies indicated that compound 1 showed a sta-
bilization with the promoter G-quadruplex that was almost two times
higher than that observed with the telomeric (a-core and a-coreTT) or
TBA G-quadruplex DNAs, and showed an approximately nine times
higher order of specific stabilization than it did with the dsDNA. Con-
sidering our present results, we strongly conclude that the incorpo-
ration of ferrocene into the cyclic NDI derivatives likely improved
their stability with the G-quadruplex DNAs. Furthermore, compounds
1 and 2 showed higher ΔTm values than those obtained with previ-
ously investigated ligands (approximately 2 or 9 °C for cyclic NDI
with cyclohexyl and benzene parts, respectively, Table 1).
Based on the results of the binding and thermal stabilization stud-
ies, TRAP assays were performed to further investigate compounds 1
and 2. The investigation showed that 1 is a strong inhibitor of telom-
erase at a sub-micromolar range with an IC50 of 0.4 μM (Supporting
information, Fig. S13) whereas 2 showed an IC50 of 25 μM (unpub-
lished data). The telomerase inhibitory activity of 1 was approxi-
mately 63-times higher than that of 2 was, and this result is in agree-
ment with that of the binding affinity and thermal stability. Since the
inhibitory effect was much higher than expected, the ferrocene moi-
ety of 1 might have contributed to inhibiting the telomerase access in
some way.
In summary, the novel compound 1 was synthesized successfully
using cyclization of NDI with ferrocene using another two-linker
chain and its binding interaction with different types of G-quadru-
plex DNAs and dsDNA was investigated. Collectively, these results
suggest that the cyclic molecule 1 with an appropriate linker chain
might facilitate the development of specific binding interactions with
G-quadruplex DNAs over that with dsDNA. Therefore, compound 1
could be considered as a better prototype of a promising and important
class of ligands for G-quadruplex stabilization than the linear chain
compound 2 is. In addition, this study demonstrates the usefulness of
engineering compounds for potential therapeutic applications.
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Fig. 3. CD spectra of 1.5 μM of a-core (A), a-coreTT (B), TBA (C), c-kit (D), or c-myc (E) in 100 mM AcOH-AcOK buffer (pH 5.5) containing 100 mM KCl in addition of 1 (0,
0.38, 0.75, 0.80, 2.25, and 3.00 μM with arrow direction) at 25 °C.
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Fig. 4. Melting profiles for a-core (A), a-coreTT (B), TBA (C), c-kit (D), c-myc (E) in the absence (red curve) or presence (blue curve) of 1 with [1]: [DNA] = 2:1 in 100 mM
AcOK-AcOH buffer (pH 5.5) containing 100 mM KCl (A–C), 20 mM KCl (D), or 5 mM KCl (E). (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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